Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach

Monkeypox virus (mpox virus) outbreak has rapidly spread to 82 non-endemic countries. Although it primarily causes skin lesions, secondary complications and high mortality (1–10%) in vulnerable populations have made it an emerging threat. Since there is no specific vaccine/antiviral, it is desirable...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Anshuman, Gaur, Mahendra, Mahanandia, Nimai Charan, Subudhi, Enketeswara, Swain, Ranjit Prasad, Subudhi, Bharat Bhusan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122558/
https://www.ncbi.nlm.nih.gov/pubmed/37211001
http://dx.doi.org/10.1016/j.compbiomed.2023.106971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122558/
https://www.ncbi.nlm.nih.gov/pubmed/37211001
http://dx.doi.org/10.1016/j.compbiomed.2023.106971

Ejemplares similares